Dedicated, isolated cloud environments for each customer—no data co-mingling, no forced upgrades, and infrastructure designed specifically for FDA- and EMA-regulated trials.
A modern, highly configurable EDC that supports no-code study builds, mid-study amendments without downtime, advanced edit checks, and robust audit trails for global regulatory requirements.
Patient-centric modules for decentralized and hybrid trials, including eConsent and ePRO, designed to work on any device with accessibility, multi-language, and flexible scheduling built in.
Integrated RTSM for randomization and supply management, Captivate Coder for medical coding against industry dictionaries, and eTMF for audit-ready trial documentation across the study lifecycle.
Study build, data management, biostatistics, and training services delivered by the same experts who build and support the platform, helping teams execute faster and stay inspection-ready.
For more than a decade, Captivate has supported thousands of trials across phases, indications, and geographies—from emerging biotechs and device startups to global pharma, medtech, foundations, and academic groups.
Our approach is partnership-driven: we work as an extension of your team, aligning our configuration, services, and roadmap with your protocol, pipeline, and operational realities.
Captivate is built on the belief that powerful clinical technology should be accessible, not exclusive. Through Weidley’s Wish, our flagship philanthropic program, we provide low- or no-cost access to enterprise-grade EDC and services for underfunded research in areas like rare disease, global health, and other high-impact, underserved conditions.
This combination of innovation, hands-on partnership, and social responsibility defines how we build, support, and continually evolve Captivate—for today’s trials and tomorrow’s breakthroughs.
Discover how Captivate can support your clinical research needs. Our team is here to answer questions and show you what’s possible.
